Alder BioPharma (ALDR) Tops Q3 EPS by 15c

Alder BioPharma (NASDAQ: ALDR) reported Q3 EPS of ($0.70), $0.15 better than the analyst estimate of ($0.85).

For earnings history and earnings-related data on Alder BioPharma (ALDR) click here.

You May Also Be Interested In

• After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
• Workday shares slide 5% as revenue outlook offers little upside surprise
• Elastic N.V. (ESTC) Tops Q1 EPS by 12c, Beats on Revenue; offers FY27 Guidance